NYSE$EHC

Encompass Health Corp · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

Encompass Health's Q1 2022 results demonstrated robust demand for its services, with revenue growth driven by volume in both segments, but were impacted by strategic alternatives review costs and stock-based compensation.

Encompass Health reported strong demand for its services in Q1 2022, with revenue growth primarily driven by volume in both the inpatient rehabilitation and home health and hospice segments. The company reaffirmed its full-year 2022 guidance.

  • Revenue growth in Q1 2022 resulted primarily from volume growth in both segments.
  • Income from continuing operations attributable to Encompass Health per diluted share in Q1 2022 was impacted by higher costs associated with the strategic alternatives review and higher stock-based compensation.
  • Cash flows provided by operating activities increased 38.1% in Q1 2022.
  • Adjusted free cash flow increased 54.5%, primarily as a result of improved working capital.

Headline financials

Total Revenue

$1.33B

Previous: $1.23B+8.4%
EPS (adj)

$0.97

Previous: $1.05-7.6%
Discharges

50.8K

Previous: 47.2K+7.6%
Net patient revenue per discharge

$20.4K

Previous: $20K+2.2%
Capital Expenditures

-$115M

Previous: -$98.8M-16.6%
Free Cash Flow

-$27.7M

Previous: $8.5M-425.9%
Net Income

$87.5M

Previous: $107M-18.5%
Operating Income

-$231M

Previous: -$201M-14.7%
Gross Profit

$1.28B

Previous: $1.18B+8.4%
Cash & Equivalents

$94.2M

Previous: $224M-57.9%
Total Assets

$6.94B

Previous: $6.54B+6.1%
Stock-Based Comp

$6.1M

Previous: $2.8M+117.9%

Revenue & EPS history

Encompass Health · Revenue · Quarterly

$1.33B

Q1 2022+8.4%vs Q1 2021
Beat estimate in 10 of 16 quarters(63%)
ActualEstimate

Forward guidance

The Company is reaffirming its guidance for full-year 2022.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

+1.2%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+2.5%

Avg return

30 days after

64%

42 / 66 earnings

Positive

+11.8%

Q1 2025

Best reaction

-9.0%

Q1 2015

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.1%+5.0%+6.0%
Q4 2025+5.9%+13.9%+7.4%
Q3 2025-6.9%-6.8%-7.5%
Q1 2025+11.8%+15.4%+17.2%
Q4 2024+1.3%-0.6%+0.7%
Q3 2024+7.0%+5.8%+10.0%
Q2 2024-8.7%-7.5%+1.0%
Q1 2024+0.3%+1.4%+2.5%
Q4 2023+1.7%+1.9%+5.9%
Q3 2023-1.9%+0.9%+6.7%
Q2 2023+5.0%+6.4%+7.6%
Q1 2023+0.7%-0.6%-5.9%
Q4 2022+1.6%+3.1%-9.1%
Q3 2022+6.4%+11.1%+16.6%
Q2 2022+0.6%+4.5%-4.0%
Q1 2022+2.6%+2.5%-2.0%
Q4 2021+1.5%-2.9%+8.8%
Q3 2021-6.0%-5.8%-9.8%
Q2 2021+0.7%+3.5%-4.1%
Q1 2021-1.6%-2.7%-2.5%
Q4 2020-3.9%-6.2%-6.1%
Q3 2020-2.6%-3.0%+25.9%
Q2 2020+4.5%+3.1%-6.4%
Q1 2020-1.1%-7.1%+6.4%
Q4 2019+0.4%+3.1%-2.6%
Q3 2019-5.8%+2.0%+5.5%
Q2 2019-4.0%-7.4%-12.6%
Q1 2019+5.3%+3.6%-4.6%
Q4 2018-4.4%-3.5%-13.3%
Q3 2018-5.7%-4.0%+1.4%
Q2 2018+8.8%+5.9%+17.4%
Q1 2018+7.2%+7.3%+10.3%
Q4 2017+3.0%+3.9%+7.7%
Q3 2017+1.8%+2.0%+8.7%
Q2 2017+1.9%-0.2%+3.6%
Q1 2017+7.9%+10.0%+6.3%
Q4 2016+0.1%+0.5%-1.9%
Q3 2016+1.8%+0.7%+5.6%
Q2 2016+6.7%+3.1%-0.3%
Q1 2016+10.9%
Q4 2015+9.2%
Q3 2015-0.3%
Q2 2015-2.9%
Q1 2015-9.0%
Q4 2014-4.7%
Q3 2014-3.0%
Q2 2014+7.4%
Q1 2014-0.4%
Q4 2013-2.8%
Q3 2013+0.6%
Q2 2013+4.7%
Q1 2013+3.1%
Q4 2012+7.2%
Q3 2012+2.5%
Q2 2012-3.7%
Q1 2012+9.2%
Q4 2010+3.9%
Q4 2011+3.9%
Q3 2011-1.0%
Q2 2011-9.0%
Q1 2010+0.4%
Q1 2011+2.5%
Q4 2008+7.8%
Q3 2010+2.2%
Q2 2010-1.0%
Q4 2009-1.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro